Short Interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) Rises By 38.1%
MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Rating) was the recipient of a large increase in short interest ...
Read moreMoonLake Immunotherapeutics (NASDAQ:MLTX - Get Rating) was the recipient of a large increase in short interest ...
Read more© 2022 TheDailyStock.News